Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
PhenoMiner Database Result        View data table  |  Download data table  |  View compact data table        


Generate Chart For    
    (Chart displayed below)
Rat Strains

{{sample.term}}
Measurement Methods

{{method.term}}
Age

{{ageRange}}
Experimental Conditions

     {{ cond }}

Minimum Value:    Maximum Value:    Sex:


 
Options:  View chart  |  Download data table  |  View compact data table
Study IDStudyExperiment NameExperiment NotesStrain Ont IDStrainSexAge# of AnimalsSample NotesClinical Measurement Ont IDPhenotypeFormulaClinical Measurement NotesAverage TypeValueUnitsSEMSDMethod Ont IDMethodMethod SiteMethod DurationMethod NotesPost Insult TypePost Insult Time ValuePost Insult Time UnitConditionsRecord IDCondition 1Condition 2Condition 3aCondition 3b
2378Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.kidney plasma flow traitRS:0000742WKYmale0 days11CMO:0002782renal plasma flow to body weight ratio2.28ml/min/100g0.070.2322MMO:0000636p-aminohippurate analysis by liquid phase colorimetry0.0unx168daysunilateral nephrectomy (for 28 days) then vehicle control condition99990unilateral nephrectomy (for 28 days)vehicle control condition
2378Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.kidney plasma flow traitRS:0000742WKYmale0 days17CMO:0002782renal plasma flow to body weight ratio1.72ml/min/100g0.110.4535MMO:0000636p-aminohippurate analysis by liquid phase colorimetry0.0unx168daysunilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition99991unilateral nephrectomy (for 28 days)streptozotocin (35 mg/kg) vehicle control condition
2378Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.kidney plasma flow traitRS:0000742WKYmale0 days17CMO:0002782renal plasma flow to body weight ratio3.3ml/min/100g0.110.4535MMO:0000636p-aminohippurate analysis by liquid phase colorimetry0.0unx168daysunilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 154 days)99992unilateral nephrectomy (for 28 days)streptozotocin (35 mg/kg) bosentan (100 mg/kg/d) (for 154 days)
2378Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.kidney plasma flow traitRS:0000742WKYmale0 days16CMO:0002782renal plasma flow to body weight ratio3.15ml/min/100g0.130.52MMO:0000636p-aminohippurate analysis by liquid phase colorimetry0.0unx168daysunilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days)99993unilateral nephrectomy (for 28 days)streptozotocin (35 mg/kg) enalapril (10 mg/kg/d) (for 154 days)
2378Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.kidney plasma flow traitRS:0000742WKYmale0 days16CMO:0002782renal plasma flow to body weight ratio3.19ml/min/100g0.130.52MMO:0000636p-aminohippurate analysis by liquid phase colorimetry0.0unx168daysunilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) and bosentan (100 mg/kg/d) (for 154 days)99994unilateral nephrectomy (for 28 days)streptozotocin (35 mg/kg) enalapril (10 mg/kg/d) (for 154 days)bosentan (100 mg/kg/d) (for 154 days)
2378Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.kidney plasma flow traitRS:0000742WKYmale0 days7CMO:0002782renal plasma flow to body weight ratio2.16ml/min/100g0.180.4762MMO:0000636p-aminohippurate analysis by liquid phase colorimetry0.0unx28daysunilateral nephrectomy (for 28 days) then vehicle control condition99950unilateral nephrectomy (for 28 days)vehicle control condition
2378Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.kidney plasma flow traitRS:0000742WKYmale0 days8CMO:0002782renal plasma flow to body weight ratio3.09ml/min/100g0.180.5091MMO:0000636p-aminohippurate analysis by liquid phase colorimetry0.0unx28daysunilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition99951unilateral nephrectomy (for 28 days)streptozotocin (35 mg/kg) vehicle control condition
2378Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.kidney plasma flow traitRS:0000742WKYmale0 days8CMO:0002782renal plasma flow to body weight ratio2.33ml/min/100g0.090.2546MMO:0000636p-aminohippurate analysis by liquid phase colorimetry0.0unx28daysunilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 14 days)99952unilateral nephrectomy (for 28 days)streptozotocin (35 mg/kg) bosentan (100 mg/kg/d) (for 14 days)
2378Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.kidney plasma flow traitRS:0000742WKYmale0 days8CMO:0002782renal plasma flow to body weight ratio2.32ml/min/100g0.110.3111MMO:0000636p-aminohippurate analysis by liquid phase colorimetry0.0unx28daysunilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days)99953unilateral nephrectomy (for 28 days)streptozotocin (35 mg/kg) enalapril (10 mg/kg/d) (for 14 days)
2378Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.kidney plasma flow traitRS:0000742WKYmale0 days6CMO:0002782renal plasma flow to body weight ratio2.42ml/min/100g0.090.2205MMO:0000636p-aminohippurate analysis by liquid phase colorimetry0.0unx28daysunilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) and bosentan (100 mg/kg/d) (for 14 days)99954unilateral nephrectomy (for 28 days)streptozotocin (35 mg/kg) enalapril (10 mg/kg/d) (for 14 days)bosentan (100 mg/kg/d) (for 14 days)